动物间歇低氧实验系统ProOx-100

 产品特点及参数             

1. 为动物低氧、高氧实验模型的建立提供合适的气体环境

2. 按照设定气体浓度自动配比气体，维持恒定的氧气浓度环境。无需在箱体外混合比例气体，确保实验氧浓度的准确，节省气源

3. 低氧箱采用进口透明聚丙烯酸甲酯板（PMMA）材质，坚固耐用

4. 7英寸大屏触摸屏控制，人性化界面，操作简单

5. 具有多功能可编程控制器：动态控制，实现多种氧浓度控制方式，可进行急性缺氧实验、慢性缺氧实验、间歇式低氧等实验

6. 监测参数：温度、湿度、氧气O2浓度、二氧化碳浓度

7. 非色散红外（NDIR）二氧化碳传感器，测量范围：0～5000ppm测量精度：±30ppm

8. 进口电化学氧气O2浓度检测器，测量范围：0-25%vol，测量分辨率：0.01%，线性度好，检测准确、使用寿命长。具有温度补偿机制

9. 温度检测：进口高精度数字铂电阻温度传感器

10. 氧气浓度变化动态曲线，直观了解氧气浓度变化的过程

11. 氧气浓度自动校准：通过控制器对传感器快速校准

12. 湿度传感器和除湿设计，能有效的降低动物实验过程中呼吸产生的水汽对动物的影响

13. 特有的气体混合及循环机制，保证箱体内气体浓度的均一

14. 高性能电磁阀，性能稳定，超长寿命

15. 具有废气处理功能，保证排出的废气不会污染实验环境

应用领域             

睡眠呼吸暂停综合症、心肌缺血缺氧、脑缺血损伤、肺动脉高压、高原反应、肿瘤、呼吸疾病、造血功能等多种领域的动物建模研究。

 

规格型号             

名称	型号	功能	参考容纳动物数量	备注
动物间歇低氧实验系统	ProOx-100	多功能控制氧浓度	大鼠：5-10只 小鼠：20-30只	可直接放1个大鼠笼、或2个小鼠笼
动物间歇低氧实验系统	ProOx-100-N	多功能控制氧浓度 具有恒温功能	适合新生鼠 新生鼠10-20只	恒温功能，适合新生鼠 舱体小
动物间歇低氧实验系统	ProOx-100-D	多功能控制氧浓度	大鼠：10-20只 小鼠：40-60只	可直接放2个大鼠笼、或4个小鼠笼
动物间歇低氧实验系统	ProOx-100-T	多功能控制氧浓度	大鼠：20-30只 小鼠：60-90只	系统自带动物专用鼠笼
动物间歇低氧实验系统	ProOx-100-MC	多功能控制氧浓度 双通道独立控制		可选大鼠笼或小鼠笼
豪华工具套装	Kit-NV			适合持续一个月间歇低氧的应用

使用客户名单

相关文献

[1]Ma Jinqiu,Wang Chenyun,Sun Yunbo,Pang Lulu,Zhu Siqing,Liu Yijing,Zhu Lin,Zhang Shouguo,Wang Lin,Du Lina. Comparative study of oral and intranasal puerarin for prevention of brain injury induced by acute high-altitude hypoxia.[J] International Journal of Pharmaceutics,2020,591

[2]Guijuan Chen,Kang Cheng,Yun Niu,Li Zhu,Xueting Wang.Epicatechin gallate prevents inflammatory response in hypoxia-activated microglia and cerebral edema by inhibiting NF-κB signaling.[J]Archives of Biochemistry and Biophysics ,Volume 729, 109393;

[3]Yapeng,LuPanpanChang,WangwangDing,JiangpeiBian,DanWang,XuetingWang,QianqianLuo,XiaomeiWu,LiZhu.Pharmacological inhibition of mitochondrial division attenuates simulated high-altitude exposure-induced cerebral edema in mice: Involvement of inhibition of the NF-κB signaling pathway in glial cells.[J] European Journal of Pharmacology,Volume 929,2022,175137

[4]Jun-Yu Wei, Miao-Yue Hu, Xiu-Qi Chen, Feng-Ying Lei, Jin-Shuang Wei, Jie Chen, Xuan-Kai Qin & Yuan-Han Qin .Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner, [J] European Journal of Pharmacology,Renal Failure, 44:1, 2056-2065

[5]Yilan Wang, Zherui Shen, Caixia Pei, Sijing Zhao, Nan Jia, Demei Huang, Xiaomin Wang, Yongcan Wu, Shihua Shi, Yacong He, Zhenxing Wang,Eleutheroside B ameliorated high altitude pulmonary edema by attenuating ferroptosis and necroptosis through Nrf2-antioxidant response signaling, [J] Biomedicine & Pharmacotherapy, Volume 156, 2022,113982

[6]Fang Zhao, Yan Meng, Yue Wang, Siqi Fan, Yu Liu,Xiangfeng Zhang, Chenyang Ran, Hongxin Wang and Meili Lu,Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway.[J] Frontiers in Pharmacology,10.3389/fphar.2022.920977

[7]Xu Y, Kong X, Li J, Cui T, Wei Y, Xu J, Zhu Y , Zhu X. “Mild Hypoxia Enhances the Expression of HIF and VEGF and Triggers the Response to Injury in Rat Kidneys.” [J]. Front. Physiol. 12:690496. doi: 10.3389/fphys.2021.690496

[8]Liang Xie, Qinhan Wu, Weiping Hu, Xu Wu, Guiling Xiang, Shengyu Hao, Han Guo, Shanqun Li. “Impact of histaminergic H3 receptor antagonist on hypoglossal nucleus in chronic intermittent hypoxia conditions.” [J]. Psychopharmacology.

[9]Li Huang, Tianyou Li, Min Zhou, Mengyan Deng, Lidong Zhang, Long Yi, Jundong Zhu, Xiaohui Zhu, Mantian Mi. “Hypoxia Improves Endurance Performance by Enhancing Short Chain Fatty Acids Production via Gut Microbiota Remodeling.” [J]. Front. Microbiol. 12:820691

[10]Yanhong Pei a b, Lifei Huang c, Tong Wang c, Qinhan Yao a, Yanrong Sun a, Yan Zhang a, Xiaomei Yang a, Jiliang Zhai d, Lihua Qin a, Jiajia Xue c, Xing Wang c, Hongquan Zhang a b, Junhao Yan.”Bone marrow mesenchymal stem cells loaded into hydrogel/nanofiber composite scaffolds ameliorate ischemic brain injury. materialstoday ADVANCES, Volume 17, March 2023, 100349.

[11]Zhang, C., Sun, Y., Guo, Y. et al. “JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension. “[J].Cell Death Discov. 9, 98 (2023).

[12]Fang Zhao, Yan Meng, Yue Wang, Siqi Fan, Yu Liu,Xiangfeng Zhang, Chenyang Ran, Hongxin Wang and Meili Lu. “Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway” .[J]. Frontiers in Pharmacology,10.3389/fphar.2022.920977

[13]Chenyu Xu, Jun Xu, Chunfang Zou, Qian Li, Shan Mao, Ying Shi, Yan Tan, Wei Gu, Liang Ye. “Chronic Intermittent Hypoxia Regulates CaMKII-Dependent MAPK Signaling to Promote the Initiation of Abdominal Aortic Aneurysm.” [J]. Hindawi, Oxidative Medicine and Cellular Longevity Volume 2021, Article ID 2502324, 15 pages

[14]Jing Zhang, Jian-Zhong Jiang, Jun Xu, Chen-Yu Xu, Shan Mao, Ying Shi, Wei Gu, Chun-Fang Zou, Yue-Ming Zhao, Liang Ye. “Identification of Novel Biomarkers for Abdominal Aortic Aneurysm Promoted by Obstructive Sleep Apnea.” [J]. Elsevier Inc. This is an open access article under the CC BY-NC-ND license

[15]Zhang Q, Xu L, Bai Y, Chen P, Xing M, Cai F, Wu Y, Song W. “Intermittent hypoxia-induced enhancement of sociability and working memory associates with CNTNAP2 upregulation.” [J]. Front. Mol. Neurosci. 16:1155047.

[16]Chen Zhang, Yue Sun, Yingying Guo, Jingjing Xu, Haiyan Zhao. “JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension.” [J]. Cell Death Discovery (2023) 9:98.